SCHEMBL30349503

SCHEMBL30349503

Cc1ccc(CC(=O)OC(C)(C)C)cc1Cl

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 2/20 0.46
CA1 P00915 1/20 0.46
MTNR1A P48039 1/20 0.44
MTNR1B P49286 1/20 0.44
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
SIGMAR1 Q99720 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2D6 P10635 1/20 0.41
TSHR P16473 1/20 0.41
HTT P42858 2/20 0.40
ALOX15 P16050 1/20 0.40
CRHBP P24387 1/20 0.40
CRHR2 Q13324 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
OPRK1 P41145 1/20 0.40
ALDH1A1 P00352 5/20 0.40
NPSR1 Q6W5P4 1/20 0.40
KDM4E B2RXH2 2/20 0.39
HPGD P15428 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26091012 1.00 CA2 (0.46) CA2CA1MTNR1AMTNR1BMEN1
SCHEMBL25487719 0.88 MTNR1A (0.44) CA2CA1MTNR1AMTNR1BMEN1
SCHEMBL10229485 0.82 ALDH1A1 (0.53) CA2CA1SIGMAR1CYP1A2CYP2D6
SCHEMBL15181144 0.80 CA2 (0.46) CA2CA1KMT2AHTTALDH1A1
SCHEMBL46585 0.80 MTNR1A (0.43) CA2CA1MTNR1AMTNR1BMEN1
SCHEMBL1829911 0.79 TSHR (0.59) TSHRL3MBTL1HPGDSMN1; SMN2
SCHEMBL28553472 0.79 MTNR1A (0.51) MTNR1AMTNR1BMEN1KMT2AHTT
SCHEMBL2427540 0.78 MAPT (0.56) MTNR1AMTNR1BKMT2ACYP1A2CYP2D6
SCHEMBL1725721 0.78 MTNR1A (0.45) MTNR1AMTNR1BMEN1KMT2AHTT
SCHEMBL2432439 0.78 ALDH1A1 (0.45) MTNR1AMTNR1BTSHRALOX15ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023069731-A1 COMPOUNDS THAT MEDIATE PROTEIN DEGRADATION AND METHODS OF USE THEREOF MONTE ROSA THERAPEUTICS, INC. (US) 2023-04-27 WO disclosed